Short-term Celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model

Chao-Hung Kuo; Huang-Ming Hu; Pei-Yun Tsai; I-Chen Wu; Sheau-Fang Yang; Lin-Li Chang; Jaw-Yuan Wang; Chang-Ming Jan; Wen-Ming Wang; Deng-Chyang Wu; Yuan Yuan
October 2009
World Journal of Gastroenterology;10/21/2009, Vol. 15 Issue 39, p4907
Academic Journal
AIM: To evaluate the optimal intervention point of a selective cyclooxygenase-2 (COX-2) inhibitor, Celecoxib, for inhibiting Helicobacter pylori (H pylori)-associated gastric carcinogenesis in Mongolian gerbils (MGs). METHODS: One hundred and twelve MGs were divided into six groups (A-F). One hundred gerbils were inoculated with H pylori (groups A-E). Twelve gerbils were inoculated with vehicle broth only (group F). After 4 wk, they were given N'-methyl-N'-nitro-N-nitroso-guanidine (MNNGG) (50 µg/mL) in the drinking water for 20 wk. In groups B-E, the animals were given the stock Celecoxib (10 mg/kg per day) diet from the 21st, 31st, 21st and 41st week respectively. The periods of administering Celecoxib were 30, 20, 20, and 15 wk respectively. On the 51st week, the animals were sacrificed for histological examination. Local PCNA expression was examined by the immunohistochemistry method. The expression of COX-2 protein was assessed by Western Blot. Analysis used the x² test. The difference was regarded as significant when P value was less than 0.05. RESULTS: Seventeen percent (17/100) of H pylori-infected MGGs developed gastric cancer. All of these lesions were well-differentiated adenocarcinoma. The incidence rates of adenocarcinoma in groups A-F were 40%, 0%, 0%, 20%, 25%, and 0% respectively. The inflammatory scores were higher in group B than in other groups. There was no inflammatory response noted in group F. Celecoxib treatment resulted in a significant reduction in the proliferation of H pylori-infected mucosal cells (groups B, C and D) (P < 0..01). The expression of COX-2 protein was significantly attenuated in the groups which were Celecoxib-treated for more than 20 wk (groups B, C, D). The groups treated with Celecoxib had a significantly lower rate of advanced gastric cancer (34% vs 75%, P <0.001). There were no sudden deaths in any of the groups. CONCLUSION: Short-term treatment with Celecoxib has an anti-carcinogenic effect, and resulted in less severe inflammation and inhibited the invasive degree of gastric cancer.


Related Articles

  • New animal model of glandular stomach carcinogenesis in Mongolian gerbils infected with Helicobacter pylori and treated with a chemical carcinogen. Shimizu, Nobuyuki; Inada, Ken-ichi; Tsukamoto, Tetsuya; Nakanishi, Hayao; Ikehara, Yuzuru; Yoshikawa, Akemi; Kaminishi, Michio; Kuramoto, Shu; Tatematsu, Masae // Journal of Gastroenterology;1999 Supplement 11, Vol. 34, p61 

    In 1994 WHO/IARC concluded that ‘Helicobacter pylori is a definite carcinogen’ based on epidemiological studies, but there have been few reports demonstrating a relation between H. pylori and stomach cancer in animal models. We have succeeded in producing adenocarcinomas in the...

  • Helicobacter pylori and Gastric Cancer: Proving the Link. Metz, David C.; Johnson, David // American Journal of Gastroenterology;Mar1999, Vol. 94 Issue 3, p852 

    Reviews abstract of the article "Helicobacter pylori Infection Induces Gastric Cancer in Mongolian Gerbils," by T. Watanabe, M. Tada and H. Nagai, et al., published in the 1998 issue of the "Gastroenterology."

  • Effects of acetylsalicylic acid and celecoxib on the N-nitrosodiethylamine induced carcinogenesis in rat liver and esophagus. L. Bolieva; F. Dzhioev; S. Kakabadze // Bulletin of Experimental Biology & Medicine;Jan2007, Vol. 143 Issue 1, p87 

    Abstract  The effects of nonsteroid antiinflammatory drugs (acetylsalicylic acid and celecoxib) on N-nitrosodiethylamine-induced carcinogenesis in the liver and esophagus were studied in rats. The inhibitory effect of celecoxib on carcinogenesis was more pronounced (in comparison with...

  • Tumorigenesis: Hang on tight! Novak, Kristine // Nature Reviews Cancer;Sep2002, Vol. 2 Issue 9, p638 

    Discusses the role of Helicobacter pylori and elicited host inflammatory response on gastric tumorigenesis. Gastric cell synthesis of sialylated glycoconjugates; H. pylori expression of an adhesin protein; Treatment of H. pylorin infection.

  • Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Wong, Benjamin C. Y.; Lian Zhang; Jun-ling Ma; Kai-feng Pan; Ji-you Li; Lin Shen; Wei-dong Liu; Guo-shuang Feng; Xiao-dong Zhang; Jie Li; Ai-ping Lu; Xia, Harry H. X.; Shiukum Lam; Wei-cheng You // Gut;Jun2012, Vol. 61 Issue 6, p812 

    Objective Helicobacter pylori infection and overexpression of cyclo-oxygenase-2 (COX-2) are associated with gastric cancer and its precursors. To evaluate the effect of a selective COX-2 inhibitor alone and combined with H pylori eradication on the evolution of precancerous gastric lesions, a...

  • Efficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck Disease (KBD) patients. Luo, Rui; Liu, Gang; Liu, Wei; Pei, Fuxing; Zhou, Zongke; Li, Jian; Shen, Bin; Kang, Pengde; Xie, Qibing; Ma, Xin // International Orthopaedics;Sep2011, Vol. 35 Issue 9, p1409 

    The objective of this study was to compare the efficacy and tolerability of celecoxib, meloxicam and paracetamol in late Kashin-Beck disease. Adults ( n = 168) with Kashin-Beck disease were randomised in clusters to receive six week courses of celecoxib 200 mg once daily, meloxicam 7.5 mg once...

  • Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. Li-Jing Zhang; Shi-Yan Wang; Xiao-Hui Huo; Zhen-Long Zhu; Jian-Kun Chu; Jin-Cheng Ma; Dong-Sheng Cui; Ping Gu; Zeng-Ren Zhao; Ming-Wei Wang; Jun Yu; Malekzadeh, Reza; Farinati, Fabio // World Journal of Gastroenterology;6/14/2009, Vol. 15 Issue 22, p2731 

    AIM: To evaluate whether celecoxib, a selective cyclooxygenase 2 (COX-2) inhibitor, could reduce the severity of gastric precancerous lesions following Helicobacter pylori (H pylori) eradication. METHODS: H pylori-eradicated patients with gastric precancerous lesions randomly received either...

  • Usefulness of rifabutin loaded floating beads for the treatment of Helicobacter pylori infection in experimental Mongolian gerbils. Verma, Anurag; Pandit, Jayant K // International Journal of Drug Delivery;2011, Vol. 3 Issue 4, p315 

    The objective of the present study was to develop stomachspecific drug delivery system of rifabutin and to evaluate their effectiveness in eradication of Helicobacter pylori in experimental Mongolian gerbil model. Rifabutin loaded floating gellan gum beads prepared by calcium induced ionotropic...

  • Helicobacter pylori infection and gastric carcinogenesis in rodent models. Tsukamoto, Tetsuya; Toyoda, Takeshi; Mizoshita, Tsutomu; Tatematsu, Masae // Seminars in Immunopathology;Mar2013, Vol. 35 Issue 2, p177 

    Helicobacter pylori infection is an important factor for gastric carcinogenesis in human. In carcinogen-treated Mongolian gerbils, H. pylori infection enhances stomach carcinogenesis, while infection alone induced severe hyperplasia called heterotopic proliferative glands. A high-salt diet or...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics